SLXN — Silexion Therapeutics Corp
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-04-07.
Performance
Technicals
Others in Healthcare
Measured signals that fired on SLXN
| date | signal | measured base rate |
|---|---|---|
| 2026-08-14 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-07-07 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-04 | Hadar Ilan Chairman and CEO | Grant or award | 10.0K | 0.00 | 0 |
| 2026-06-04 | Shirvan Mitchell CSO and CDO | Grant or award | 6.0K | 0.00 | 0 |
| 2026-06-04 | Horenshtein Hadar Mirit CFO and Secretary | Grant or award | 7.5K | 0.00 | 0 |
| 2026-03-26 | Shirvan Mitchell CSO and CDO | Open-market sale | 22.8K | 1.36 | 31.0K |
| 2026-02-20 | Shirvan Mitchell CSO and CDO | Grant or award | 49.7K | 0.00 | 0 |
| 2026-02-20 | Peled Amnon Director | Grant or award | 7.6K | 0.00 | 0 |
| 2026-02-20 | Lushi Avner Director | Grant or award | 9.1K | 0.00 | 0 |
| 2026-02-20 | Abramov Dror Yosef Director | Grant or award | 9.1K | 0.00 | 0 |
| 2026-02-20 | Hadar Ilan Chairman and CEO | Grant or award | 64.3K | 0.00 | 0 |
| 2026-02-20 | Noy Shlomo Director | Grant or award | 9.1K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| CITADEL ADVISORS LLC | 26.8K | 20.9K |
| TWO SIGMA SECURITIES, LLC | 14.9K | 11.7K |
| MONTAG A & ASSOCIATES INC | 3.8K | 3.0K |
| UBS Group AG | 662 | 517 |
| Pflug Koory, LLC | 426 | 333 |
| JONES FINANCIAL COMPANIES LLLP | 32 | 26 |
| SBI Securities Co., Ltd. | 26 | 20 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| PRE 14A | 2026-08-14 | 2026-08-14 | on EDGAR ↗ |
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-14 | 2026-08-14 | on EDGAR ↗ |
| 8-K | 2026-08-13 | 2026-08-13 | on EDGAR ↗ |
| 8-K | 2026-08-13 | 2026-08-13 | on EDGAR ↗ |
| 424B4 | 2026-08-13 | — | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-13 | — | on EDGAR ↗ |
| EFFECT | 2026-08-11 | — | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Silexion Therapeutics Corp (SLXN) filed form 8-K · 2026-08-21 · SEC EDGAR
- Silexion Therapeutics Corp (SLXN) filed form 8-K · 2026-08-14 · SEC EDGAR
- Silexion Therapeutics Corp (SLXN) filed form 8-K · 2026-08-13 · SEC EDGAR
- Silexion Therapeutics prices $2.5M public offering · 2026-08-12
Ask the AI about SLXN
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →